Trinity Biotech (TRIB)
NASDAQ: TRIB
· Real-Time Price · USD
1.74
0.37 (27.01%)
At close: Aug 20, 2025, 3:59 PM
1.61
-7.47%
After-hours: Aug 20, 2025, 06:03 PM EDT
27.01% (1D)
| Bid | 1.72 |
| Market Cap | 18.07M |
| Revenue (ttm) | 61.56M |
| Net Income (ttm) | -31.79M |
| EPS (ttm) | -1.8 |
| PE Ratio (ttm) | -0.97 |
| Forward PE | -0.84 |
| Analyst | n/a |
| Ask | 1.75 |
| Volume | 41,070,398 |
| Avg. Volume (20D) | 4,487,975 |
| Open | 1.89 |
| Previous Close | 1.37 |
| Day's Range | 1.58 - 1.97 |
| 52-Week Range | 0.48 - 3.44 |
| Beta | 0.77 |
About TRIB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRIB
Website n/a
Next Earnings Release
Trinity Biotech is scheduled to release its earnings on
Sep 2, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 day ago
Trinity Biotech shares are trading higher after th...
Unlock content with
Pro Subscription
1 week ago
+89.11%
Trinity Biotech shares are trading higher after the company announced it received regulatory approval to begin FDA-cleared PreClara Preeclampsia Testing service.
